FCRL5 and COVID-19: In recovered COVID-19 patients, memory B cells present 1–3 months after symptom onset are also found to express FcRL5 and T-bet, suggesting that these markers may delineate a subset of long-lived memory B cells against SARS-CoV-2 [13, 29].